Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
177 studies found for:    lupus | Open Studies
Show Display Options
Download search resultsDownload the search results for:
lupus | Open Studies (177 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting The Effect of Metformin on Reducing Lupus Flares
Condition: Systemic Lupus Erythematosus
Interventions: Drug: metformin;   Drug: placebo
2 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
3 Not yet recruiting Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
Conditions: Anti-Phospholipids Syndrome (APS);   Systemic Lupus Erythematosus (SLE)
Intervention:
4 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
5 Recruiting Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Other: therapeutic education
6 Not yet recruiting Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Qi Gong
7 Recruiting Low-dose UVA1 Radiation in Cutaneous Lupus Patients
Condition: Cutaneous Lupus Erythematosus
Intervention: Device: UVA1 radiation treatment
8 Recruiting Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus (SLE);   Active Cutaneous Lupus Erythematosus (CLE)
Interventions: Drug: BIIB059;   Drug: Placebo
9 Not yet recruiting Dissemination of the Lupus Interactive Navigator
Condition: Systemic Lupus Erythematosus
Interventions: Other: LIN_NOW;   Other: LIN_WAIT
10 Not yet recruiting Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
Condition: Lupus Erythematosus
Intervention:
11 Not yet recruiting Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus
Conditions: Skin Restricted Lupus;   Psychiatric Disorders
Intervention: Biological: Biological dosage from plasma
12 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
13 Recruiting Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Other: Drug free;   Drug: HCQ;   Drug: GC+HCQ
14 Recruiting Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Conditions: Nephritis;   Lupus
Interventions: Drug: Leflunomide;   Drug: Azathioprine
15 Recruiting A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Interventions: Drug: Placebo;   Drug: Dapirolizumab pegol (DZP)
16 Recruiting Cutaneous Lupus Medication Experience Study
Condition: Cutaneous Lupus
Intervention: Drug: fluocinonide 0.05% cream
17 Recruiting A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: XmAb5871;   Biological: Placebo to match XmAb5871
18 Recruiting Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Brentuximab vedotin;   Drug: Placebo
19 Recruiting Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Chronic Cutaneous
Intervention: Drug: Etanercept
20 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.